Calmer Co International Limited · ASX:CCO

Calmer Co International — The Calmer Co International — FY2023 Earnings Presentation

17 slides from Calmer Co International's earnings presentation, Sep 8, 2023

  1. Slide 1: Annual Results and Investor Update Presentation

    For personal use only Natural solutions to calm nerves, support mind & muscle relaxation and induce sleep Annual Results and Investor Update Presentation 8th September 2023

  2. Slide 2: Table of Contents

    Table of Contents For personal use only 1 Corporate Snapshot 2 Operating Highlights 3 Financial Results 4 FY24 Growth Pillar Update

  3. Slide 3: Corporate Snapshot

    Corporate Snapshot FY2023 RESULTS HIGHLIGHTS TRADING HIGHLIGHTS For personal use only $1.78m >$4,000/day ($4.2m) Daily e-commerce sales globally Revenue FY23 Operating EBITDA (before provisions and adjustments) >$3,000/day Represents a 23% Daily e-commerce sales in USA improvement from FY22 ASX OVER

  4. Slide 4: Operating Highlights

    Operating Highlights $2.76m annualised sales based on Q4 For personal use only Sales continue to improve driven by ecommerce sales in the USA. US ecommerce growth Fiji Kava is now the number 1 instant kava brand selling on Amazon.com and August 2023 sales exceed $3,000/day. CJ Patel distribution dea

  5. Slide 5: Q4 Sales Growth

    Q4 Sales Growth Quarterly Revenues & Net Cash Outflows Used in Operations 79% increase in sales revenue in Q4 (vs Q3, 2023) For personal use only 1200 largely due to strong sales growth in ecommerce sales in the USA and new distribution partners. FijiKava® is now the number 1 instant kava brand 1000

  6. Slide 6: Group Financial Results

    For personal use only Group Financial Results FY2023 2023 has been a year of pivotal change.

  7. Slide 7: Group Profit & Loss

    Group Profit & Loss FY23 Commentary For personal use only Summary Consolidated P&L FY2023 FY23 $'000 A challenging year as we embarked on Revenue our turnaround strategy Revenue from all divisions 1,786 Total revenue 1,786 Three major adjustments and provisions Total cost of sales (1,226) influenced

  8. Slide 8: Operating Results Commentary

    Operating Results Commentary Year on Year Analysis FY23 FY22 %YoY For personal use only Total Trading Income $ 1,786,812 $ 2,050,738 -12% Total Cost of Sales $ 1,091,449 $ 1,427,261 -24% Improved results started to show in H2 and particularly in Q4 Gross Profit $ 695,363 $ 623,477 +12% H2 Operating

  9. Slide 9: Segment Analysis

    Segment Analysis Commentary FY23 FY22 For personal use only Australian sales through Chemist Warehouse and B2B ingredients fell significantly vs. FY22 High-cost Australia retail sales channels will not continue with a similar cost base We are working actively on NPD for the Australia Fiji USA Danoda

  10. Slide 10: FY24 Growth Pillars

    For personal use only FY24 Growth Pillars Progress update

  11. Slide 11: e-Commerce Focus

    e-COMMERCE FOCUS Global ecommerce Daily Sales $4,500.00 $4,000.00 Global daily ecommerce sales were >$4000 in August For personal use only $3,500.00 USA $3,000.00 Fiji Kava Instant Kava remains the #1 on Amazon USA $2,500.00 Ecommerce sales in the USA now exceed $3,000 per day $2,000.00 March April

  12. Slide 12: USA Kava Bar Market

    USA KAVA BAR MARKET Rapidly Growing Direct & B2B Sales Execution commencing in Q2 For personal use only An untapped opportunity • More than 500 kava bars now operating in the USA • The supply of kava to these retailers is unreliable • Demand is estimated to be more than 70MT per year Ready to start

  13. Slide 13: Asia Market Penetration

    ASIA MARKET PENETRATION China Distribution via RooLife Group (ASX:RLG) • First orders for the China market has been received and will ship in September For personal use only • Alibaba Tmall Global Flagship Store is established • Noble Kava and Noble Sleep products launch in October • The Calmer Co,

  14. Slide 14: Profitable Retail

    PROFITABLE RETAIL CJ Patel – Taki Mai® • Fiji and 12 Pacific Islands Launched in May 2023 • New Zealand Launched June 2023 For personal use only • CJ Patel has confirmed distribution of Taki Mai Juice shots to commence in Q3FY24 Jack’s of Fiji – Leilo® First orders of Leilo for the Fiji resorts and

  15. Slide 15: Regulatory Update

    REGULATORY UPDATE Australian Commercial Importation Program The initial 24-month period will likely be extended For personal use only under current import and Food Standards, and consultation may follow with potential for permanent changes in regulations in Australia Fiji Hemp Bill and Implementatio

  16. Slide 16: Disclaimer

    DISCLAIMER For personal use only This presentation and any Materials provided (materials) have been prepared by The Calmer Co Limited (Calmer Co) and contain general information about The Calmer Co activities and activities of its subsidiaries. By accepting the Materials and attending the Calmer Co

  17. Slide 17: Vinaka (thank you)

    For personal use only Vinaka (thank you) Anthony Noble Zane Yoshida Chief Executive Chief Operating Officer The Calmer Co The Calmer Co a.noble@thecalmerco.com zane@thecalmerco.com

The Calmer Co International — FY2023 Earnings Presentation on 6ix